Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases

AUSTIN, TX and DURHAM, NC, Feb. 13, 2024 -- Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic...

Related Keywords

Japan ,North Carolina ,United States ,Texas ,Osaka ,Japanese ,Taylor Schreiber ,Conor Richardson ,Toichi Takino ,Ono Pharmaceutical Co Ltd ,Nasdaq ,Discovery Research Of Ono ,Shattuck Labs Inc ,Exchange Commission ,Ono Pharmaceutical ,Chief Executive Officer ,Senior Executive ,Executive Director ,Shattuck Labs ,Agonist Redirected Checkpoint ,Annual Report ,Safe Harbor ,Private Securities Litigation Reform Act ,Media Contact ,Markets ,